España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Apogee Therapeutics
APGE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$41.36
-1.14
-2.68%
At close: -
$41.36
0.00
0.00%
After Hours: Jan 31, 4:00 PM EDT
Get Report
Comment
Apogee Therapeutics (APGE) Forecast
News
Earnings
Apogee Therapeutics (APGE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Apogee Therapeutics (NASDAQ:APGE) Stock
Apogee Therapeutics Stock (NASDAQ: APGE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
Guggenheim Reiterates Buy on Apogee Therapeut...
Benzinga Newsdesk
Tuesday, December 10, 2024
Apogee Therapeutics Doses First Participants ...
Benzinga Newsdesk
Tuesday, December 03, 2024
Guggenheim Reiterates Buy on Apogee Therapeut...
Benzinga Newsdesk
Monday, December 02, 2024
Wedbush Maintains Outperform on Apogee Therap...
Benzinga Newsdesk
Apogee Therapeutics Plans To Highlight Update...
Benzinga Newsdesk
Wednesday, November 27, 2024
Guggenheim Maintains Buy on Apogee Therapeuti...
Benzinga Newsdesk
Monday, November 25, 2024
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
Canaccord Genuity Initiates Coverage On Apoge...
Benzinga Newsdesk
Tuesday, November 12, 2024
Apogee Therapeutics shares are trading lower....
Benzinga Newsdesk
Apogee Therapeutics Q3 2024 Net Loss Of $(49)...
Benzinga Newsdesk
Friday, October 25, 2024
Wedbush Reiterates Outperform on Apogee Thera...
Benzinga Newsdesk
Thursday, October 24, 2024
Apogee Therapeutics Announces Results Up To 9...
Benzinga Newsdesk
Monday, August 19, 2024
Apogree Therapeutics shares are trading highe...
Benzinga Newsdesk
Apogee Therapeutics Has Initiated Dosing Of H...
Benzinga Newsdesk
Monday, August 12, 2024
Apogee Therapeutics Reported Q2 Net Loss Of $...
Benzinga Newsdesk
Sunday, July 14, 2024
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Lekha Gupta
Thursday, July 11, 2024
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, May 15, 2024
Apogee Doses First Patient In Phase 2 Atopic ...
Benzinga Newsdesk
Monday, May 13, 2024
Apogee Therapeutics Advances in Clinical Tria...
Benzinga Newsdesk
Friday, May 10, 2024
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
B of A Securities Initiates Coverage On Apoge...
Benzinga Newsdesk
Monday, March 25, 2024
Apogee Therapeutics Has Dosed First Participa...
Benzinga Newsdesk
Thursday, March 14, 2024
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Avi Kapoor
Friday, March 08, 2024
Reported Earlier, Apogee Therapeutics Prices ...
Benzinga Newsdesk
Wednesday, March 06, 2024
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
Jefferies Maintains Buy on Apogee Therapeutic...
Benzinga Newsdesk
Tuesday, March 05, 2024
Apogee Therapeutics Announces Commencement Of...
Benzinga Newsdesk
Apogee Therapeutics Files For Offering Of 6M ...
Benzinga Newsdesk
Crude Oil Down 1%; Dave Shares Jump After Q4 Results
Avi Kapoor
Stifel Maintains Buy on Apogee Therapeutics, ...
Benzinga Newsdesk
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Guggenheim Maintains Buy on Apogee Therapeuti...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Nasdaq Down 250 Points; ISM Services PMI Falls In February
Avi Kapoor
Why Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday?
Vandana Singh
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Dow Dips Over 100 Points; Target Posts Upbeat Earnings
Avi Kapoor
Market-Moving News for March 5th
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
Apogee Therapeutics 2023 Net Loss Of $(31.7)M...
Benzinga Newsdesk
Apogee Announces Interim Results from Phase 1...
Benzinga Newsdesk
Monday, March 04, 2024
Apogee To Host Conference Call And Webcast To...
Benzinga Newsdesk
Wednesday, January 03, 2024
Guggenheim Maintains Buy on Apogee Therapeuti...
Benzinga Newsdesk
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, December 20, 2023
Apogee Therapeutics shares are trading higher...
Benzinga Newsdesk
BTIG Initiates Coverage On Apogee Therapeutic...
Benzinga Newsdesk
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 28, 2023
Apogee Therapeutics Q2 Net Loss Of $18.90M Do...
Benzinga Newsdesk
Tuesday, August 08, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Benzinga Insights
Show More